Gene vaccination with naked plasmid DNA: Mechanism of CTL priming

被引:396
|
作者
Corr, M
Lee, DJ
Carson, DA
Tighe, H
机构
[1] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,SAM & ROSE STEIN INST RES AGING,LA JOLLA,CA 92093
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1996年 / 184卷 / 04期
关键词
D O I
10.1084/jem.184.4.1555
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The injection of naked plasmid DNA directly into the muscle cells of mice has been shown to induce potent humoral and cellular immune responses. The generation of a cytotoxic T lymphocyte (CTL) response after plasmid DNA injection may involve the presentation of the expressed antigen in the context of the injected myocytes' endogenous major histocompatibility (MHC)-encoded class I molecules or may use the MHC molecules of bone marrow-derived antigen presenting cells (APC) which are capable of providing co-stimulation as well. To resolve which cell type provides the specific restricting element for this method of vaccination we generated parent-->F1 bone marrow chimeras in which H-2(oxd) recipient mice received bone marrow that expressed only H-2(b) or H-2(d) MHC molecules. These mice were injected intramuscularly with naked plasmid DNA that encoded the nucleoprotein from the A/PR/8/34 influenza strain, which as a single antigen has epitopes for both H-2D(b) and H-2K(d). The resulting CTL responses were restricted to the MHC haplotype of the bone marrow alone and not to the second haplotype expressed by the recipient's myocytes. The role of somatic tissues that express protein from injected plasmids may be to serve as a reservoir for that antigen which is then transferred to the APC. Consequently, our data show that the mechanism of priming in this novel method for vaccination uses the MHC from bone marrow-derived APC, which are efficient at providing all of the necessary signals for priming the T cell.
引用
收藏
页码:1555 / 1560
页数:6
相关论文
共 50 条
  • [1] Mechanism of priming following naked plasmid DNA injection.
    Corr, M
    Lee, DJ
    Tighe, H
    Abeyratne, A
    Carson, DA
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 881 - 881
  • [2] Naked Plasmid DNA for Gene Therapy
    Shimamura, Munehisa
    Morishita, Ryuichi
    CURRENT GENE THERAPY, 2011, 11 (06) : 433 - 433
  • [3] Plasmid DNA vaccination: Mechanism of antigen presentation
    Maripat Corr
    Helen Tighe
    Springer Seminars in Immunopathology, 1997, 19 : 139 - 145
  • [4] Plasmid DNA vaccination: mechanism of antigen presentation
    Corr, M
    Tighe, H
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1997, 19 (02): : 139 - 145
  • [5] Gene delivery of naked plasmid DNA by retrograde coronary vein perfusion
    Sirou, M
    Haruo, H
    Kiminori, K
    Ritsuo, W
    Takashi, S
    Satoru, K
    Katsuharu, H
    Makoto, K
    Jun, K
    Yoshihusa, A
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (05) : S190 - S190
  • [6] Absorption of naked plasmid DNA in keratinocyte
    Wang, ZJ
    Hengge, UR
    JOURNAL OF GENE MEDICINE, 2003, 5 (03): : S27 - S27
  • [7] Naked DNA for vaccination and treatment
    Molling, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (23) : 757 - 760
  • [8] Intradermal vaccination with naked DNA
    Bouloc, A
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1998, 125 (10): : 749 - 750
  • [9] Plasmid DNA vaccination
    Huygen, K
    MICROBES AND INFECTION, 2005, 7 (5-6) : 932 - 938
  • [10] Percutaneous Pulmonary Artery Gene Transfer Using Naked Plasmid DNA • 120
    Laurence H. Keller
    Richard S. Vander Heide
    Thomas L'Ecuyer
    Pediatric Research, 1997, 41 (Suppl 4) : 22 - 22